Clinical Trial Update: Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients [Phase 3]

View source ↗

Summary

Phase 3 trial testing a combination of dry powder tobramycin and nebulized colistin inhalation in cystic fibrosis with pulmonary manifestations has completed. S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Colistin inhalation (colistin)
• Tobramycin (dry powder inhalation) (tobramycin)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Cystic Fibrosis With Pulmonary Manifestations | Phase 3 | Status: COMPLETED